A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).
Status:
Unknown status
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
Patients who are currently symptomatic and have been diagnosed with BPH by a physician may
qualify for this 20-week study. Patients must not be diabetic, must not have prostate cancer
and must not have had any surgery to repair your prostate or treat your BPH. Patients will
first undergo a phone screening to confirm their eligibility and interest and to rule out any
exclusionary history or medications. Eligible patients will be scheduled to come in to the
clinic to sign an Informed Consent Form. Patients will then undergo blood and urine tests, a
complete physical examination and history and answer several questionnaires to determine
their eligibility. Patients will have a total of at least 7-8 visits over 20 weeks to the
clinic during this study.Qualified patients receive free study medication, free medical care
(physical examinations, EKG, laboratory tests) for the duration of the study.